Who owns Immunome Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IMNM from SEC Form 13F filings across 201 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 201 institutions disclosed 118.0M shares of Immunome Inc. worth $2.50B — about 104.2% of shares outstanding; the largest disclosed holder is T. Rowe Price Investment Management, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
201
13F holders
$2.50B
value, 2026 filers
104.2%
of shares outstanding (118.0M sh)
33
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IMNM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | T. Rowe Price Investment Management, Inc. | 19.7M | $417.0M | 0.3% | 17.4% | +20.2% |
| 2 | FMR LLC | 17.0M | $360.0M | 0.0% | 15% | +0.1% |
| 3 | BlackRock, Inc. | 8.8M | $186.6M | 0.0% | 7.8% | +7.8% |
| 4 | STATE STREET CORP | 5.5M | $116.4M | 0.0% | 4.9% | +1.8% |
| 5 | WELLINGTON MANAGEMENT GROUP LLP | 5.2M | $110.4M | 0.0% | 4.6% | +10.1% |
| 6 | Redmile Group, LLC | 4.9M | $104.1M | 7.0% | 4.3% | -11.6% |
| 7 | PRIMECAP MANAGEMENT CO/CA/ | 4.6M | $97.1M | 0.1% | 4% | -4.3% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 4.6M | $96.4M | 0.0% | 4% | +2.7% |
| 9 | Driehaus Capital Management LLC | 4.3M | $92.1M | 0.5% | 3.8% | +6.0% |
| 10 | ENAVATE SCIENCES GP, LLC | 3.6M | $76.6M | 22.2% | 3.2% | 0.0% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 2.8M | $58.4M | 0.0% | 2.4% | +7.6% |
| 12 | MORGAN STANLEY | 2.4M | $51.0M | 0.0% | 2.1% | -15.3% |
| 13 | SILVERARC CAPITAL MANAGEMENT, LLC | 2.0M | $42.7M | 4.4% | 1.8% | +9.0% |
| 14 | JPMORGAN CHASE & CO | 1.8M | $39.0M | 0.0% | 1.6% | -33.5% |
| 15 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.8M | $37.6M | 0.0% | 1.6% | -38.0% |
| 16 | Sofinnova Investments, Inc. | 1.7M | $36.5M | 1.9% | 1.5% | +1.1% |
| 17 | READYSTATE ASSET MANAGEMENT LP | 1.6M | $34.0M | 1.2% | 1.4% | +23.3% |
| 18 | GOLDMAN SACHS GROUP INC | 1.5M | $32.0M | 0.0% | 1.3% | +37.3% |
| 19 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $28.6M | 0.0% | 1.2% | +34.0% |
| 20 | PRINCIPAL FINANCIAL GROUP INC | 1.3M | $28.6M | 0.0% | 1.2% | -2.1% |
| 21 | BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1.3M | $26.5M | 0.0% | 1.1% | +13.9% |
| 22 | Woodline Partners LP | 1.0M | $21.2M | 0.1% | 0.9% | -36.5% |
| 23 | NORTHERN TRUST CORP | 968,346 | $20.5M | 0.0% | 0.9% | +7.7% |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 886,193 | $18.8M | 0.0% | 0.8% | +4.0% |
| 25 | MetLife Investment Management, LLC | 859,076 | $18.2M | 0.1% | 0.8% | +1438.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.